spacer
The Healthcare Sales & Marketing Network celebrates 25 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Acura Pharmaceuticals 

 HSMN NewsFeed - 17 Mar 2017
Acura Pharmaceuticals and MainPointe Pharmaceuticals Announce Deal for Nexafed(R) Products
Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 23 May 2016
Egalet Settles Patent Litigations with Purdue Pharma
Biopharmaceuticals Litigation
 HSMN NewsFeed - 8 May 2014
Acura Pharmaceuticals Announces Settlement of Patent Litigation With Ranbaxy Inc.
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 8 Nov 2011
Nautilus Neurosciences Appoints Peter Lankau as Executive Chairman
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Jul 2011
Robert Jones Appointed President & CEO and to the Board of Directors of Acura Pharmaceuticals, Inc.
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Jul 2011
Acura Pharmaceuticals, Inc. Announces the Retirement of William A. Sumner From Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 May 2011
Acura Pharmaceuticals, Inc. Announces Appointment of Robert Jones as Interim President and CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Apr 2011
Acura Pharmaceuticals, Inc. Announces Andrew Reddick, President & CEO, to Take Medical Leave
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Apr 2010
Galen Partners Invests in Nautilus Neurosciences, Inc.
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 2 Jul 2009
Acura and King Receive FDA Complete Response Letter Regarding Acurox(R)
Biopharmaceuticals FDA
 HSMN NewsFeed - 2 Jan 2009
New Drug Application Submitted For Acurox(r) Tablets
Biopharmaceuticals
 HSMN NewsFeed - 2 Sep 2008
Acura Pharmaceuticals, Inc. Announces Return of President and CEO From Medical Leave
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 May 2008
King Pharmaceuticals Exercises Option to License Third Opioid Product Utilizing Acura's AVERSION Technology
Biopharmaceuticals Licensing
 HSMN NewsFeed - 24 Apr 2008
King Pharmaceuticals and Acura Pharmaceuticals Announce Completion of Patient Enrollment for Pivotal Phase III Clinical Trial Evaluating ACUROX(TM)
Biopharmaceuticals
 HSMN NewsFeed - 24 Mar 2008
Acura Pharmaceuticals, Inc. Names Robert B. Jones Chief Operating Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 31 Oct 2007
King Pharmaceuticals and Acura Pharmaceuticals Enter Agreement to Develop and Commercialize Immediate Release Pain Medicines Utilizing Acura's Aversion(R) (Abuse-Deterrent) Technology
Biopharmaceuticals Drug Delivery
Return to NewsFeed  
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.